Need Training?

Build a solid foundation in science, formulation and product development—find out more!

Most Popular in:

Animal Alternatives

56

Researchers Develop Non-animal, Dendritic-based Sensitizer Test

25

Ethics, Ethics Everywhere

15

Non-animal Transdermal Diffusion Model Testing for Cosmetic Actives and Formulations

9

Appointment of Commissioner Borg May Jeopardize Animal-alternative Test Progress

9

Alternatives to Animal Testing: A Review of Trends and Perspectives

7

EPA, L'Oréal Collaborate to Build Animal-Alternative Test Methods

7

API Campaigns Against Animal Testing for Cosmetics

5

NICEATM Calls for Scientific Experts and Data on Eye Testing

5

ICCVAM Recommends Non-animal Endocrine Disruptor Screening

5

A Synthetic Tissue-based In vitro Ocular Irritation Assay

Email This Item! Print This Item!

Colipa and EU Kick-off Animal Alternative Initiative

Posted: March 4, 2011

page 2 of 2

*The six research projects are:

  • Project SCR&Tox (Stem Cells for Relevant Efficient Extended and Normalized Toxicology), coordinated by Prof. Marc Peschanski, INSERM (France)
  • Project HeMiBio (Hepatic Microfluidic Bioreactor), coordinated by Prof. Catherine Verfaillie, Katholieke Universiteit Leuven (Belgium)
  • Project Detective, “Detection of endpoints and biomarkers of repeated dose toxicity using in vitro systems,” coordinated by Prof. Jürgen Hescheler, Universität zu Köln – Universitätsklinikum (Germany)
  • Project COSMOS, “Integrated In Silico Models for the Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety,” coordinated by Prof. Mark Cronin, Liverpool John Moores University (UK)
  • Project NOTOX, “Predicting long-term toxic effects using computer models based onsystems characterization of organotypic cultures," coordinated by Prof. Elmar Heinzle, Saarland University - Biochemical Engineering Institute (Germany)
  • Project ToxBank, “Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in Toxicology,” coordinated by Prof. Emilio Benfenati from Istituto di Ricerche Farmacologiche Mario Negri (Italy) and Dr. Barry Hardy, Douglas Connect (Switzerland)